• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

中国肌萎缩侧索硬化症患者的健康相关生活质量、心理健康及患者报告结局

Health-Related Quality of Life, Psychological Health, and Patient-Reported Outcomes of Amyotrophic Lateral Sclerosis Patients in China.

作者信息

Dhakal Dilip, Chen Congzhou, Zhang Bo, Li Guanqiao

机构信息

Vanke School of Public Health, Tsinghua University, Beijing 100084, China.

Guangzhou Magpie Pharmaceuticals Co., Ltd., Guangzhou 510700, China.

出版信息

Brain Sci. 2025 Jun 28;15(7):696. doi: 10.3390/brainsci15070696.

DOI:10.3390/brainsci15070696
PMID:40722288
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12293507/
Abstract

This study explored the health-related quality of life (HRQoL), psychological health, and patient-reported outcomes (PROs) of patients with amyotrophic lateral sclerosis (ALS) in China, providing insights for enhancing clinical care. A cross-sectional study was conducted among Chinese ALS patients between February and May 2024. Demographics, clinical characteristics, and PROs were assessed. HRQoL and psychological health were evaluated via the 5-item amyotrophic lateral sclerosis assessment questionnaire (ALSAQ-5) and the 4-item patient health questionnaire (PHQ-4), respectively. Spearman's rank correlation, multiple linear regression, and the Kruskal-Wallis H test were used to analyze associations between clinical factors, HRQoL, and psychological health. A total of 237 participants aged 46-65 years (63.3%) were included. The mean ALSAQ-5 score was 64.86±19.34, indicating an impaired HRQoL, whereas the mean PHQ-4 score (5.82 ± 4.10,) suggested varied degree of anxiety and depression. Age, disease duration, ALS severity, fatigue, stress, and pain severity, and respiratory support were significantly associated with HRQoL ( < 0.05). Age, stress severity, and pain severity were significant predictors of psychological distress ( < 0.01). Patients reported diagnostic delay, profound lifestyle changes (96.4%), fear of paralysis (84.8%), and death (49.8%). Most patients (80.6%) expressed a strong desire to stop ALS progression, prioritizing treatments that improve breathing, muscle weakness, swallowing, and mobility issues. ALS profoundly impacts patients' HRQoL and psychological health. Integrating PROs into clinical care strategies is crucial for improving patient outcomes and guiding treatment priorities.

摘要

本研究探讨了中国肌萎缩侧索硬化症(ALS)患者的健康相关生活质量(HRQoL)、心理健康状况以及患者报告结局(PROs),为改善临床护理提供了见解。2024年2月至5月对中国ALS患者进行了一项横断面研究。评估了人口统计学、临床特征和PROs。分别通过5项肌萎缩侧索硬化症评估问卷(ALSAQ - 5)和4项患者健康问卷(PHQ - 4)评估HRQoL和心理健康。采用Spearman等级相关性分析、多元线性回归分析和Kruskal - Wallis H检验分析临床因素、HRQoL和心理健康之间的关联。共纳入237名年龄在46 - 65岁之间的参与者(63.3%)。ALSAQ - 5的平均得分为64.86±19.34,表明HRQoL受损,而PHQ - 4的平均得分(5.82±4.10)表明存在不同程度的焦虑和抑郁。年龄、病程、ALS严重程度、疲劳、压力、疼痛严重程度和呼吸支持与HRQoL显著相关(<0.05)。年龄、压力严重程度和疼痛严重程度是心理困扰的显著预测因素(<0.01)。患者报告存在诊断延迟、生活方式发生深刻变化(96.4%)、对瘫痪的恐惧(84.8%)和对死亡的恐惧(49.8%)。大多数患者(80.6%)强烈希望阻止ALS进展,优先选择改善呼吸、肌肉无力、吞咽和行动问题的治疗方法。ALS对患者的HRQoL和心理健康有深远影响。将PROs纳入临床护理策略对于改善患者结局和指导治疗重点至关重要。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bb0e/12293507/68723476dd85/brainsci-15-00696-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bb0e/12293507/e4ae26398475/brainsci-15-00696-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bb0e/12293507/68723476dd85/brainsci-15-00696-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bb0e/12293507/e4ae26398475/brainsci-15-00696-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bb0e/12293507/68723476dd85/brainsci-15-00696-g002.jpg

相似文献

1
Health-Related Quality of Life, Psychological Health, and Patient-Reported Outcomes of Amyotrophic Lateral Sclerosis Patients in China.中国肌萎缩侧索硬化症患者的健康相关生活质量、心理健康及患者报告结局
Brain Sci. 2025 Jun 28;15(7):696. doi: 10.3390/brainsci15070696.
2
Mechanical ventilation for amyotrophic lateral sclerosis/motor neuron disease.肌萎缩侧索硬化症/运动神经元病的机械通气
Cochrane Database Syst Rev. 2017 Oct 6;10(10):CD004427. doi: 10.1002/14651858.CD004427.pub4.
3
Associations between psychological factors and health-related quality of life and global quality of life in patients with ALS: a systematic review.肌萎缩侧索硬化症患者心理因素与健康相关生活质量及总体生活质量的关联:一项系统评价
Health Qual Life Outcomes. 2016 Jul 20;14(1):107. doi: 10.1186/s12955-016-0507-6.
4
How Does Shame Relate to Clinical and Psychosocial Outcomes in Knee Osteoarthritis?羞耻感与膝关节骨关节炎的临床及心理社会结局有何关联?
Clin Orthop Relat Res. 2025 Apr 1;483(4):558-570. doi: 10.1097/CORR.0000000000003329. Epub 2024 Dec 3.
5
Mechanical ventilation for amyotrophic lateral sclerosis/motor neuron disease.肌萎缩侧索硬化症/运动神经元病的机械通气
Cochrane Database Syst Rev. 2013 Mar 28(3):CD004427. doi: 10.1002/14651858.CD004427.pub3.
6
Is Kinesiophobia Associated With Quality of Life, Level of Physical Activity, and Function in Older Adults With Knee Osteoarthritis?恐动症与老年膝骨关节炎患者的生活质量、身体活动水平及功能是否相关?
Clin Orthop Relat Res. 2025 Apr 1;483(4):667-676. doi: 10.1097/CORR.0000000000003278. Epub 2024 Oct 9.
7
Health-related quality of life of informal carers in ALS: a systematic review of person reported outcome measures.肌萎缩侧索硬化症非正式照料者的健康相关生活质量:对患者报告结局指标的系统评价
Qual Life Res. 2025 Jun 25. doi: 10.1007/s11136-025-04012-y.
8
Interventions for fatigue and weight loss in adults with advanced progressive illness.针对患有晚期进行性疾病的成年人疲劳和体重减轻的干预措施。
Cochrane Database Syst Rev. 2012 Jan 18;1:CD008427. doi: 10.1002/14651858.CD008427.pub2.
9
Treatment for sialorrhea (excessive saliva) in people with motor neuron disease/amyotrophic lateral sclerosis.运动神经元病/肌萎缩侧索硬化症患者流涎(唾液过多)的治疗。
Cochrane Database Syst Rev. 2022 May 20;5(5):CD006981. doi: 10.1002/14651858.CD006981.pub3.
10
Educational and psychological interventions for managing atopic dermatitis (eczema).管理特应性皮炎(湿疹)的教育和心理干预措施。
Cochrane Database Syst Rev. 2024 Aug 12;8(8):CD014932. doi: 10.1002/14651858.CD014932.pub2.

本文引用的文献

1
Real-world evidence of riluzole on survival and ALSFRS change in a Chinese ALS cohort.利鲁唑对中国肌萎缩侧索硬化症队列患者生存率及肌萎缩侧索硬化功能评分变化影响的真实世界证据
Neurodegener Dis Manag. 2025 Apr-Jun;15(2-3):77-87. doi: 10.1080/17582024.2025.2488235. Epub 2025 Apr 4.
2
Factors associated with psychological distress in patients with amyotrophic lateral sclerosis: A retrospective medical records study.与肌萎缩侧索硬化症患者心理困扰相关的因素:一项回顾性病历研究。
J Psychosom Res. 2024 Dec;187:111915. doi: 10.1016/j.jpsychores.2024.111915. Epub 2024 Sep 3.
3
Accurate personalized survival prediction for amyotrophic lateral sclerosis patients.
准确的肌萎缩侧索硬化症患者个体化生存预测。
Sci Rep. 2023 Nov 24;13(1):20713. doi: 10.1038/s41598-023-47935-7.
4
Diagnostic delay in amyotrophic lateral sclerosis.肌萎缩侧索硬化症的诊断延迟。
Eur J Neurol. 2023 Sep;30(9):2595-2601. doi: 10.1111/ene.15874. Epub 2023 May 30.
5
Assessing the psychometric properties of quality of life measures in individuals with amyotrophic lateral sclerosis: a systematic review.评估肌萎缩侧索硬化症患者生活质量测量工具的心理测量学特性:系统评价。
Qual Life Res. 2023 Sep;32(9):2447-2462. doi: 10.1007/s11136-023-03377-2. Epub 2023 Mar 7.
6
Amyotrophic lateral sclerosis: a neurodegenerative disorder poised for successful therapeutic translation.肌萎缩侧索硬化症:一种神经退行性疾病,有望成功实现治疗转化。
Nat Rev Drug Discov. 2023 Mar;22(3):185-212. doi: 10.1038/s41573-022-00612-2. Epub 2022 Dec 21.
7
Pain in amyotrophic lateral sclerosis: a narrative review.肌萎缩侧索硬化症中的疼痛:一项叙述性综述。
J Yeungnam Med Sci. 2022 Jul;39(3):181-189. doi: 10.12701/jyms.2022.00332. Epub 2022 Jun 8.
8
Drug treatments and interactions, disease progression and quality of life in ALS patients.肌萎缩侧索硬化症患者的药物治疗和相互作用、疾病进展和生活质量。
Amyotroph Lateral Scler Frontotemporal Degener. 2022 Aug;23(5-6):415-423. doi: 10.1080/21678421.2021.2019279. Epub 2021 Dec 29.
9
Quality of life, disability, and clinical variables in amyotrophic lateral sclerosis.肌萎缩侧索硬化症患者的生活质量、残疾和临床变量。
Arq Neuropsiquiatr. 2022 Mar;80(3):255-261. doi: 10.1590/0004-282X-ANP-2021-0201.
10
Health-related quality of life in amyotrophic lateral sclerosis using EQ-5D-5L.使用 EQ-5D-5L 评估肌萎缩侧索硬化症患者的健康相关生活质量。
Health Qual Life Outcomes. 2021 Jul 20;19(1):181. doi: 10.1186/s12955-021-01822-9.